| Literature DB >> 30029598 |
Tezera Moshago Berheto1, Sven Gudmund Hinderaker2, Mbazi Senkoro3, Hannock Tweya4, Tekalign Deressa5, Yimam Getaneh5, Gulilat Gezahegn6.
Abstract
BACKGROUND: Ethiopia has achieved a high coverage of antiretroviral treatment (ART), but maintaining lifelong care is still a great challenge. Mental illnesses often co-exist with HIV/AIDS and may compromise the retention on ART. In order to improve prolonged retention in ART care, basic training in mental health care was introduced for ART providers, but this hasn't been evaluated yet. The aim of this study was to examine if this training has improved patient retention in care.Entities:
Keywords: ART; Mental health care; Retention on care
Mesh:
Substances:
Year: 2018 PMID: 30029598 PMCID: PMC6053784 DOI: 10.1186/s12889-018-5821-y
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Flowchart for generic classification of mental problems and training plan. (Source: Detecting and managing common child and adult mental health problems in HIV care training package participants manual, second edition 2010, FMOH, Addis Ababa, Ethiopia)
Baseline and follow-up characteristics of participants under ART with mental health trained and non-trained providers, Ethiopia
| Characteristics |
| ||
|---|---|---|---|
| Exposed n (%) | Unexposed n (%) | ||
| ART Enrolment year | |||
| 2005–2007 | 408 (22.1) | 1569 (25.6) | 0.08 |
| 2008–2010 | 639 (34.6) | 2179 (35.5) | |
| 2011–2013 | 433 (23.4) | 1244 (20.3) | |
| 2014–2017 | 369 (20.0) | 1138 (18.6) | |
| Gender | |||
| Male | 747 (40.3) | 2602 (42.3) | 0.13 |
| Female | 1107 (59.7) | 3553 (57.7) | |
| total | 1854 (23.1) | 6155 (76.9) | |
| WHO stage at entry | |||
| Stage I | 408 (24.3) | 1272 (20.9) | 0.01 |
| Stage II | 348 (19.1) | 1592 (26.1) | |
| Stage III | 866 (47.5) | 2600 (42.6) | |
| Stage IV | 203 (11.1) | 634 (10.4) | |
| Functional status at entry | |||
| Bedridden | 130 (7.3) | 353 (5.9) | 0.07 |
| Ambulatory | 580 (32.5) | 1515 (25.3) | |
| Working | 1072 (60.2) | 4116 (68.8) | |
| TB Coinfection | |||
| No (−ve) | 1467 (79.1) | 5138 (83.5) | 0.01 |
| Yes (+ve) | 387 (20.9) | 1017 (16.5) | |
| INH prophylaxis | |||
| Yes | 865 (46.7) | 3222 (52.3) | 0.01 |
| No | 989 (53.3) | 2933 (47.7) | |
| Ever Regimen Substitution | |||
| No | 1326 (71.5) | 4503 (73.2) | 0.23 |
| Yes | 528 (28.5) | 1652 (26.8) | |
| Ever Regimen Switch | |||
| No | 1819 (98.1) | 6101 (99.1) | 0.01 |
| Yes | 35 (1.9) | 54 (0.9) | |
| Viral load Test ( | 270 | 1242 | |
| Detectable | 41 (15.2) | 305 (24.6) | 0.01 |
| Not Detectable | 229 (84.8) | 937 (75.4) | |
Retention in ART care during follow-up attending exposed and unexposed ART providers in Ethiopia
| Follow-up time in month | ||||
|---|---|---|---|---|
| Cumulative probability (95% CI) of retention in care after attrition from deaths | Cumulative probability (95% CI) of retention in care after any attrition | |||
| Exposed | Unexposed | Exposed | Unexposed | |
| 6 | 94.5 (93.4, 95.5) | 95.4 (94.8, 95.9) | 92.4 (91.1, 93.6) | 90.9 (90.1, 91.6) |
| 12 | 92.1 (90.8, 93.3) | 93.5 (92.8, 94.1) | 88.1 (86.4, 89.5) | 84.5 (83.6, 85.4) |
| 18 | 90.6 (89.1, 91.9) | 93.0 (92.3, 93.7) | 86.0 (84.3, 87.6) | 81.2 (80.1, 82.2) |
| 24 | 89.6 (88, 90.9) | 92.6 (91.86, 93.3 | 84.3 (82.5, 86.0) | 79.1 (78.0, 80.1) |
| 48 | 82.9 (80.8, 84.8) | 90.8 (89.93, 91.6) | 76.9 (74.6, 78.9) | 73.3 (72.0, 74.5) |
| 144 | 73.2 (68.4, 77.4) | 81.3 (77.5, 84.6) | 63.3 (58.6, 67.6) | 52.6 (47.3, 57.5) |
CI Confidence interval); Exposed Exposed to mental health care
Fig. 2Kaplan-Meir estimates of attrition by exposure status for mental health care adjusted for age, baseline CD4 count, baseline functional status and WHO clinical stage at entry
Analysis of factors associated with attrition among HIV infected patients Under ART in South Ethiopia
| Variables | Attrition n (%) | AHR (95% CI) |
|---|---|---|
| Mental health | ||
| Unexposed | 1750 (79.6) | 1.2 (1.1, 1.4) |
| Exposed | 1063 (48.4) | Ref |
| Age (IQR) | 31.75 (11.13) | 0.9 (0.99, 1.0) |
| BaseCD4count (IQR) | 220.51 (760.59) | 0.9 (0.95, 1.0) |
| Baseline WHO clinical | ||
| WHO stage [I] | 298 (13.9) | Ref |
| WHO stage [II] | 421 (19.6) | 1.1 (0.9, 1.3) |
| WHO stage [III] | 1042 (48.5) | 1.2 (1.01, 1.4) |
| WHO stage [IV] | 386 (18) | 1.5 (1.2, 1.8) |
| CTM prophylaxis | ||
| (No) | 314 (14.3) | 1.2 (1.01, 1.3) |
| Yes | 1884 (85.7) | Ref |
| INH prophylaxis | 445 (20.2) | 0.2 (0.14, 0.2) |
| (Yes) | ||
| No | 1753 (79.8) | Ref |
| TB Coinfection | ||
| (Yes) | 455 (20.7) | Ref |
| No | 1743 (79.3) | 0.7 (0.6, 0.7) |
| Gender | ||
| Female | 1135 (51.6) | Ref |
| Male | 1063 (48.4) | 1.2 (1.1, 1.3) |
| LowestCD4 (IQR) | 164.05 (163.07) | 0.9 (0.9, 0.99) |
| Regimen Substitution (No) | 1845 (83.9) | 0.14 (0.12, 0.2) |
| Substitution (yes) | 353 (16.1) | Ref |
| Baseline functional status | ||
| Working | 1135 (51.6) | 0.6 (0.5, 0.7) |
| Ambulatory | 726 (33.0) | 0.5 (0.4, 0.5) |
| Bedridden | 280 (12.7) | Ref |
| ART Enrolment year | ||
| 2005–2007 | 610 (28) | Ref |
| 2008–2010 | 830 (38.2) | 1.22 (1.1, 1.36) |
| 2011–2013 | 435 (20) | 1.5 (1.31, 1.73) |
| 2014–2017 | 300 (13.8) | 2.3 (1.96 2.75) |
‘Analyzed by Cox proportional hazard regression, with adjusted hazard ratio (AHR) with 95% confidence interval